Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Docusign Inc (NQ: DOCU )

56.03 -0.87 (-1.53%)
Streaming Delayed Price Updated: 12:20 PM EDT, Jul 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Docusign Inc

< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
33 34 Next >
DocuSign Stock Just Got a Whole Lot More Interesting -- or Did It?
Investors should not jump the gun just yet. 
Via The Motley Fool
Where Will DocuSign Stock Be in 1 Year?
The e-signature service leader's stock could be bottoming out. 
Via The Motley Fool
Rivian, GlobalFoundries Joining Nasdaq 100 Index; Apple Chipmaker, China Stocks Falling Off
Rivian and GlobalFoundries lead Dec. 19 additions to the Nasdaq 100. 
Via Investor's Business Daily
Is DocuSign Stock on the Road to Recovery After Its Spectacular Fall From Grace?
The e-signature specialist increased investor confidence with a beat and raise. 
Via The Motley Fool
Annual Changes To The Nasdaq-100 Index For 2023
The Nasdaq-100 Index is composed of the 100 largest non-financial companies listed on The Nasdaq Stock Market. The reconstituted index (effective Dec. 19, 2022) has 6 new members, replacing such... 
Via Talk Markets
Why DocuSign Stock Is Soaring Higher Today
Strong third-quarter results sent the stock climbing. 
Via The Motley Fool
DocuSign CEO's Turnaround Vision Debated Amid Earnings Beat
DocuSign stock popped Friday after it reported earnings and revenue that topped estimates amid sharply lowered expectations. 
Via Investor's Business Daily
DOCU & COST Earnings Follow Up
DocuSign and Costco reported earnings Thursday afternoon. 
Via Talk Markets
Why Ambrx Biopharma Shares Are Trading Higher By Over 550%? Here Are 52 Stocks Moving In Friday's Mid-Day Session
Gainers Ambrx Biopharma Inc. (NYSE: AMAM) shares jumped 551.4% to $2.67 after the company announced preliminary Phase 2 results from its ACE-Breast-03 study showing a 57.1% overall response rate. 
Via Benzinga
Most Active Equity Options For Midday - Friday, Dec. 9
Here are the most active equity options for midday. 
Via Talk Markets
DocuSign (DOCU) Q3 2023 Earnings Call Transcript
DOCU earnings call for the period ending September 30, 2022. 
Via The Motley Fool
DocuSign Earnings Preview
Via Benzinga
Why Are Semiconductor Stocks Up Today?
Semiconductor stocks are climbing higher on Friday thanks to a major Q4 earnings beat from a major player in the market! 
Via InvestorPlace
12 Information Technology Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Is Grom Social (GROM) Stock Down 62% Today?
Grom Social (GROM) stock is taking a beating on Friday after the social media company priced a public offering of its shares. 
Via InvestorPlace
5 Investors Betting Big on DocuSign (DOCU) Stock
DocuSign is surging after an impressive third-quarter earnings report. Here are the top institutional investors still betting on DOCU stock. 
Via InvestorPlace
Looking At DocuSign's Recent Unusual Options Activity
A whale with a lot of money to spend has taken a noticeably bullish stance on DocuSign. Looking at options history for DocuSign (NASDAQ:DOCU) we detected 14 strange trades. 
Via Benzinga
2 Top-Performing Nasdaq Tech Stocks in a Volatile Market
Even in a bear market, some companies perform well. 
Via The Motley Fool
Netflix To Rally Around 29%? Here Are 10 Other Price Target Changes For Friday
Wells Fargo raised Netflix, Inc. (NASDAQ: NFLX) price target from $300 to $400. Wells Fargo also upgraded the stock from Equal Weight to Overweight. Netflix shares rose 0.6% to close at $310.26 on... 
Via Benzinga
12 Information Technology Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Autolus Therapeutics Shares Are Trading Lower By Around 26%; Here Are 28 Stocks Moving Premarket
Gainers Baudax Bio, Inc. (NASDAQ: BXRX) shares rose 48.2% to $6.03 in pre-market trading after jumping over 20% on Thursday. Baudax Bio initiated Phase II clinical trial evaluating BX1000 in patients... 
Via Benzinga
Broadcom, DocuSign And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
Nasdaq, S&P 500 Futures Stay Afloat As Traders Turn Attention To Producer Price Inflation Report; Broadcom's Earnings Could Lift Chip Stocks
Trading in the index futures suggests that U.S. stocks could get off to a slightly positive start on Friday. Notwithstanding the early signals, two key economic data will likely direct trading... 
Via Benzinga
Lululemon, Broadcom And 3 Stocks To Watch Heading Into Friday
With US stock futures trading higher this morning on Friday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Why DocuSign Stock Is Ripping Higher After Hours
DocuSign Inc (NASDAQ: DOCU) shares are trading higher in Thursday's after-hours session after the company reported better-than-expected financial results and  
Via Benzinga
12 Information Technology Stocks Moving In Thursday's After-Market Session
Via Benzinga
7 Tech Stocks to Sell Before They Topple in 2023
It's much harder now than in 2021 to find tech stocks to sell, but some tech names are still dramatically overvalued. 
Via InvestorPlace
10 Information Technology Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
US Stocks Priming For Fidgety Start Amid Persisting Recession Fears; China & Casino Stocks, GameStop, Costco In Focus
The index futures were pointing to a modestly higher opening on Thursday, as a lack of visibility worries the market to no end. In the run-up to a series of key economic catalysts kickstarting on... 
Via Benzinga
Earnings Scheduled For December 8, 2022
Companies Reporting Before The Bell • Ciena (NYSE:CIEN) is likely to report quarterly earnings at $0.08 per share on revenue of $849.88 million. 
Via Benzinga
< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
33 34 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.